Company

Anxo Pharmaceutical Co. Ltd

Headquarters: Taipei, Taiwan

TWSE: 6677 +1.06%

Market Cap

TW$1.47 Billion

TWD as of Jan. 1, 2025

US$44.7 Million

Market Cap History

Anxo Pharmaceutical Co. Ltd Categories

Taiwan Healthcare Drug Manufacturers—Specialty & Generic
Taiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic

Anxo Pharmaceutical Co. Ltd market capitalization over time

Evolution of Anxo Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Anxo Pharmaceutical Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. It offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, gastroenterology, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. The company was founded in 2003 and is headquartered in Taipei, Taiwan.

Stocks & Indices

Anxo Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: TWSE: 6677 wb_incandescent

Details

Headquarters:

No.206, Nanking East Road

8th Floor – 3 Sec. 2 Zhongshan District

Taipei, 10489

Taiwan

Phone: 886 2 2504 2121

Fax: 886 2 2508 4245